4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-032804
SVP and General Counsel sold 2,880 shares at $42.00 ($120,960)
- SVP and General Counsel acquired 2,880 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Stacy L SVP and General Counsel | 2020-05-26 | Option exercise | +1,109 | $7.80 | $8,650 | 2,409 | D |
| Taylor Stacy L SVP and General Counsel | 2020-05-26 | Option exercise | +1,771 | $6.55 | $11,600 | 4,180 | D |
| Taylor Stacy L SVP and General Counsel | 2020-05-26 | Sale | −2,880 | $42.00 | $120,960 | 1,300 | D |
| Derivatives | |||||||
| Taylor Stacy L SVP and General Counsel | 2020-05-26 | Option exercise · Stock Option (Right to Buy) | −1,109 | 40,581 | D | ||
| Taylor Stacy L SVP and General Counsel | 2020-05-26 | Option exercise · Stock Option (Right to Buy) | −1,771 | 38,959 | D | ||
| Open-market sales · 2,880 sh · avg $42.00 · $120,960 | |||||||
Loading xslF345X03/doc4.xml…